| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $15.00B | -5.2% |
| R&D Expense | $68.0M | -25.3% |
| SG&A Expense | $2.38B | -1.9% |
| Operating Income | -$17.72B | -5728.6% |
| Pre-tax Income | -$18.89B | — |
| Income Tax | -$4.39B | -9061.8% |
| Net Income | -$14.50B | — |
| EPS (Basic) | -$50.41 | — |
| EPS (Diluted) | -$50.41 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.88B | -56.3% |
| Short-term Investments | $1.10B | -11.4% |
| Accounts Receivable | $1.27B | +6.3% |
| Inventory | $380.6M | -16.4% |
| Current Assets | $5.13B | -36.6% |
| Total Assets | $43.02B | -29.4% |
| Current Liabilities | $12.36B | +112.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$99.4M | -107.9% |
| Capital Expenditures | $965.7M | -37.5% |
| Investing Cash Flow | -$1.40B | +53.9% |
| Financing Cash Flow | -$910.3M | -120.3% |
| Free Cash Flow | -$1.07B | -264.5% |
| — |
| Long-term Debt |
| $18.66B |
| -27.3% |
| Total Liabilities | $37.20B | -8.6% |
| Stockholders' Equity | $5.77B | -71.4% |